KIF20A and metastatic malignant neoplasm in the lymph nodes: There was no significant association between KIF20A expression and OS or PFS in the subgroup of patients with subgroup with T1-2 NPC; the subgroup without lymph node metastasis (N0) and early clinical stage disease (stage I–II) (data not shown).